Skip to main content

Pegaptanib Ophthalmic Dosage

Applies to the following strengths: 0.3 mg

Usual Adult Dose for Macular Degeneration

0.3 mg via intravitreal injection into the affected eye once every 6 weeks.

Comments: No additional benefit has been demonstrated with dose levels above 0.3 mg.

Use: Treatment of neovascular (wet) age-related macular degeneration (AMD).

Renal Dose Adjustments

Data not available.

Liver Dose Adjustments

Data not available.


Safety and efficacy have not been established in patients younger than 18 years.

Consult WARNINGS section for additional precautions.


Data not available.

Other Comments

Administration Advice:

Storage Requirements:



Patient Advice:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.